about
Pharmaco fMRI: Determining the functional anatomy of the effects of medicationOptogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications.Treatment of early onset schizophrenia: recent trends, challenges and future considerations.Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.Use of functional imaging across clinical phases in CNS drug development.The behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addiction.Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants.
P2860
Q28079241-7F8C256A-DC65-40DD-B741-AC590EE21EFAQ33968713-C81F1FBD-FF5D-479A-A105-5556E055C073Q35864793-C2E0D3D5-6495-4F49-BC9D-8EDCA0B4250DQ36389112-697AB60E-8A17-4F73-949F-6DF5DB9A950BQ36685572-2971A3BB-D0FB-4B7A-8148-66C44E8AAEC6Q37065259-EAE1841A-BA7F-4B4E-A1CB-04A0DE158817Q37381671-3D06D746-E047-4344-9DE5-14D362979B61Q41881431-3CF49125-FE3A-40A3-858F-88C7193078F1
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biomarkers in development of psychotropic drugs.
@ast
Biomarkers in development of psychotropic drugs.
@en
type
label
Biomarkers in development of psychotropic drugs.
@ast
Biomarkers in development of psychotropic drugs.
@en
prefLabel
Biomarkers in development of psychotropic drugs.
@ast
Biomarkers in development of psychotropic drugs.
@en
P2860
P1476
Biomarkers in development of psychotropic drugs
@en
P2093
K Wiedemann
P2860
P304
P577
2011-01-01T00:00:00Z